We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+19.36%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.05B
AUM Growth
+$259M
Cap. Flow
+$4.36M
Cap. Flow %
0.21%
Top 10 Hldgs %
24.09%
Holding
255
New
12
Increased
112
Reduced
101
Closed
15

Top Buys

Rank Stock Value
1
OSK icon
Oshkosh
OSK
+$14.9M
2
UPWK icon
Upwork
UPWK
+$13.9M
3
TTI icon
TETRA Technologies
TTI
+$10.1M
4
PBH icon
Prestige Consumer Healthcare
PBH
+$8.64M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.86M

Top Sells

Rank Stock Value
1
AEHR icon
Aehr Test Systems
AEHR
+$16.9M
2
FN icon
Fabrinet
FN
+$11.8M
3
CEVA icon
CEVA Inc
CEVA
+$11.4M
4
FOLD
Amicus Therapeutics
FOLD
+$11.1M
5
GTLS
Chart Industries
GTLS
+$7.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33.48%
2 Technology 28.09%
3 Industrials 14.98%
4 Consumer Discretionary 7.96%
5 Communication Services 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WMT icon
226
Walmart Inc
WMT
$845B
$439K 0.02%
3,873
– –
GBCI icon
227
Glacier Bancorp
GBCI
$6B
$360K 0.02%
6,978
-1,936
-22% -$93.3K
RCKT icon
228
Rocket Pharmaceuticals
RCKT
$362M
$330K 0.02%
96,469
+4,582
+5% +$15.2K
TER icon
229
Teradyne
TER
$59.8B
$314K 0.02%
+650
New +$245K
MCO icon
230
Moody's
MCO
$81.6B
$310K 0.02%
685
-4
-0.6% -$1.8K
PG icon
231
Procter & Gamble
PG
$337B
$305K 0.01%
2,079
– –
MSFT icon
232
Microsoft
MSFT
$3.68T
$292K 0.01%
784
– –
WDFC icon
233
WD-40
WDFC
$2.64B
$280K 0.01%
1,150
– –
CDW icon
234
CDW
CDW
$18.8B
$245K 0.01%
1,741
-961
-36% -$121K
MRK icon
235
Merck
MRK
$358B
$238K 0.01%
1,850
– –
ZBH icon
236
Zimmer Biomet
ZBH
$17.6B
$236K 0.01%
2,737
-926
-25% -$81.2K
MRSH
237
Marsh
MRSH
$84.4B
$225K 0.01%
1,350
– –
SBUX icon
238
Starbucks
SBUX
$113B
$215K 0.01%
+2,100
New +$211K
J icon
239
Jacobs Solutions
J
$16.5B
$207K 0.01%
1,645
-1,800
-52% -$221K
PH icon
240
Parker-Hannifin
PH
$119B
$201K 0.01%
+205
New +$188K
ADMA icon
241
ADMA Biologics
ADMA
$2.08B
– –
-300,744
Closed -$2.71M
AMPH icon
242
Amphastar Pharmaceuticals
AMPH
$1.01B
– –
-187,348
Closed -$3.67M
AZTA icon
243
Azenta
AZTA
$1.35B
– –
-81,301
Closed -$1.72M
CMRC
244
Commerce.com Inc Series 1
CMRC
$295M
– –
-219,121
Closed -$585K
DVN icon
245
Devon Energy
DVN
$55B
– –
-6,453
Closed -$325K
FOLD
246
DELISTED
Amicus Therapeutics
FOLD
– –
-770,711
Closed -$11.1M
GO icon
247
Grocery Outlet
GO
$1.11B
– –
-327,550
Closed -$2.31M
HAS icon
248
Hasbro
HAS
$13B
– –
-3,328
Closed -$312K
KBR icon
249
KBR
KBR
$4.54B
– –
-6,328
Closed -$233K
KTOS icon
250
Kratos Defense & Security Solutions
KTOS
$8.63B
– –
-26,697
Closed -$1.88M
7 8 9
10
11

Similar funds

ABTD
Arvest Bank Trust Division Dewey, Oklahoma $2.05B AUM 30.62% 1-Year Est. Return
CFA
Capstone Financial Advisors Downers Grove, Illinois $2.05B AUM 19.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $2.05B AUM 30.99% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $2.05B AUM 4.29% 1-Year Est. Return
SIC
Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return
FWTB
First Western Trust Bank Denver, Colorado $2.05B AUM 0.32% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $2.06B AUM 24.94% 1-Year Est. Return

Rice Hall James & Associates's Q2 2026 Portfolio in Review

As of Q2 2026, Rice Hall James & Associates held 255 positions worth $2.05B, up 14% from $1.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q2 2026 filing shows 12 new, 112 increased, 101 reduced and 15 closed positions. Its largest new stake was Oshkosh: 106,011 shares worth $16.3M. The largest sale was Aehr Test Systems, an estimated $16.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q2 2026 buy was Oshkosh: 106,011 shares worth $16.3M.
  • Rice Hall James & Associates added most to Upwork in Q2 2026, an estimated $13.9M increase.
  • Rice Hall James & Associates's biggest Q2 2026 reduction was Aehr Test Systems, cutting an estimated $16.9M.
  • Rice Hall James & Associates fully exited Amicus Therapeutics in Q2 2026, selling an estimated $11.1M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $2.05B portfolio in Q2 2026.
  • Rice Hall James & Associates opened 12 new positions and closed 15 in Q2 2026.
  • Rice Hall James & Associates's portfolio value rose 14% quarter-over-quarter to $2.05B.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.